Targeting oxidative stress and metabolic dysfunctionin amyotrophic lateral sclerosis. KU Leuven
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and
fatal neurodegenerative disorder leading to the death of the patient
within three to five years after diagnosis. Oxidative stress and
dysregulated metabolism are both extensively linked to ALS. Given
the lack of efficient treatment possibilities for ALS, this project aims to
elucidate the therapeutic potential of modulating oxidative ...